Torrent Pharmaceuticals Ltd
TORNTPHARMTorrent Pharmaceuticals Ltd
TORNTPHARMPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
58.12 | 15.28 | 0.90% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
49.70 | 6.30 | 0.53% |
Forecast & Ratings
Detailed Forecast from 27 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products.
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 6,912.50 | 6,038.99 | 6,248.67 | 7,729.85 | 8,060.61 | 8,061.48 | 8,704.60 | 9,665.29 | 10,874.13 | 11,319.00 | ||||||||||
Raw Materials | 1,725.04 | 1,931.39 | 2,035.67 | 2,136.25 | 2,300.05 | 2,425.66 | 2,368.15 | 2,569.00 | 2,841.22 | 7,630.00 | ||||||||||
Power & Fuel Cost | 92.59 | 107.98 | 118.77 | 132.46 | 128.19 | 122.94 | 144.19 | 155.28 | 145.20 | |||||||||||
Employee Cost | 842.35 | 993.41 | 1,135.25 | 1,403.79 | 1,429.04 | 1,439.62 | 1,526.45 | 1,677.69 | 1,984.40 | |||||||||||
Selling & Administrative Expenses | 847.92 | 964.14 | 1,084.65 | 1,299.49 | 1,317.15 | 1,155.10 | 1,278.57 | 1,502.70 | 1,674.65 | |||||||||||
Operating & Other expenses | 639.63 | 441.50 | 226.24 | 1,074.76 | 594.52 | 381.17 | 1,244.11 | 873.43 | 714.72 | |||||||||||
EBITDA | 2,764.97 | 1,600.57 | 1,648.09 | 1,683.10 | 2,291.66 | 2,536.99 | 2,143.13 | 2,887.19 | 3,513.94 | 3,689.00 | ||||||||||
Depreciation/Amortization | 237.55 | 306.92 | 408.60 | 617.69 | 654.38 | 657.79 | 662.16 | 706.59 | 808.27 | 811.00 | ||||||||||
PBIT | 2,527.42 | 1,293.65 | 1,239.49 | 1,065.41 | 1,637.28 | 1,879.20 | 1,480.97 | 2,180.60 | 2,705.67 | 2,878.00 | ||||||||||
Interest & Other Items | 183.98 | 205.56 | 308.48 | 503.75 | 450.71 | 352.94 | 255.06 | 333.44 | 353.56 | 299.00 | ||||||||||
PBT | 2,343.44 | 1,088.09 | 931.01 | 561.66 | 1,186.57 | 1,526.26 | 1,225.91 | 1,847.16 | 2,352.11 | 2,579.00 | ||||||||||
Taxes & Other Items | 610.20 | 154.54 | 252.90 | 125.38 | 161.85 | 274.38 | 448.73 | 601.93 | 695.73 | 777.00 | ||||||||||
Net Income | 1,733.24 | 933.55 | 678.11 | 436.28 | 1,024.72 | 1,251.88 | 777.18 | 1,245.23 | 1,656.38 | 1,802.00 | ||||||||||
EPS | 51.21 | 27.58 | 20.03 | 12.89 | 30.28 | 36.99 | 22.96 | 36.79 | 48.94 | 53.24 | ||||||||||
DPS | 17.50 | 7.00 | 7.00 | 8.50 | 16.00 | 17.50 | 24.00 | 22.00 | 28.00 | 28.00 | ||||||||||
Payout ratio | 0.34 | 0.25 | 0.35 | 0.66 | 0.53 | 0.47 | 1.05 | 0.60 | 0.57 | 0.53 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Torrent Pharmaceuticals Ltd | 63.23 | 15.28 | 0.90% |
Sun Pharmaceutical Industries Ltd | 44.52 | 6.35 | 0.76% |
Cipla Ltd | 28.83 | 4.43 | 0.88% |
Mankind Pharma Ltd | 53.92 | 10.77 | — |
Price Comparison
Compare TORNTPHARM with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Torrent Pharmaceuticals Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Kotak Emerging Equity Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.4832% | Percentage of the fund’s portfolio invested in the stock 1.00% | Change in the portfolio weight of the stock over the last 3 months -0.22% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 25/75 (-3) |
UTI Flexi Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.2897% | Percentage of the fund’s portfolio invested in the stock 1.10% | Change in the portfolio weight of the stock over the last 3 months -0.11% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 19/70 (0) |
Nippon India Large Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.1865% | Percentage of the fund’s portfolio invested in the stock 0.57% | Change in the portfolio weight of the stock over the last 3 months 0.57% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 43/76 (+28) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Trend In Dividends
TORNTPHARM has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Current dividend yield is 0.90%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹9.05 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJun 21, 2024
Dividend/Share
₹6.00
Ex DateEx Date
Jun 21, 2024
Cash Dividend
Ex DateEx DateFeb 12, 2024
Dividend/Share
₹22.00
Ex DateEx Date
Feb 12, 2024
Cash Dividend
Ex DateEx DateJun 23, 2023
Dividend/Share
₹8.00
Ex DateEx Date
Jun 23, 2023
Cash Dividend
Ex DateEx DateFeb 3, 2023
Dividend/Share
₹14.00
Ex DateEx Date
Feb 3, 2023
Cash Dividend
Ex DateEx DateJun 3, 2022
Dividend/Share
₹15.00
Ex DateEx Date
Jun 3, 2022
Capri Global Capital Ltd, Marico Ltd, Honeywell Automation India Ltd, Laxmi Organic Industries Ltd are among the other stocks to see a surge in volumes on BSE today, 30 October 2024.Torrent Pharmaceuticals Ltd registered volume of 106.33 lakh shares by 10:47 IST on BSE, a 2179.99 fold spurt over two-week average daily volume of 4878 shares. The stock slipped 2.38% to Rs.3,134.50. Volumes stood at 7419 shares in the last session.Capri Global Capital Ltd clocked volume of 3.17 lakh shares by 10:47 IST on BSE, a 34.85 times surge over two-week average daily volume of 9093 shares. The stock gained 13.53% to Rs.209.80. Volumes stood at 5128 shares in the last session.Marico Ltd recorded volume of 1.91 lakh shares by 10:47 IST on BSE, a 9.7 times surge over two-week average daily volume of 19653 shares. The stock gained 3.87% to Rs.653.15. Volumes stood at 26022 shares in the last session.Honeywell Automation India Ltd witnessed volume of 744 shares by 10:47 IST on BSE, a 4.3 times surge over two-week average daily volume of 173 shares. The stock dropped 7.54% to Rs.45,297.20. Volumes stood at 128 shares in the last session.Laxmi Organic Industries Ltd saw volume of 2.9 lakh shares by 10:47 IST on BSE, a 4.05 fold spurt over two-week average daily volume of 71540 shares. The stock increased 8.61% to Rs.274.35. Volumes stood at 83736 shares in the last session.Powered by Capital Market - Live
Revenue from operations rose 8.60% year on year (YoY) to Rs 2,889 crore in the quarter ended 30 September 2024. Profit before tax stood at Rs 661 crore in September 2024 quarter, up 18.24% from Rs 559 crore posted in same quarter last year. Operating EBITDA stood at Rs 939 crore in Q2 FY25, registering a growth of 13.81% as against Rs 825 crore reported in Q2 FY24. The company's India revenue grew by 13% YoY to Rs 1,632 crore in Q2 FY25, led by outperformance in focus therapies. As per All India Organization of Chemists & Druggists (AIOCD) secondary market data, IPM growth for the quarter was 8%. Torrent's chronic business grew at 14% versus IPM growth of 9%, driven by strong revival in cardiac divisions and continued traction in anti-diabetes (OAD) new launches. Torrent Pharma's Brazil revenue rose by 4% to Rs 263 crore and on constant currency terms revenues was up by 17% at R$ 174 million. As per IQVIA, market growth for the quarter was 8%. Growth was aided by performance of top brands, new launches and growth in generic segment. The Germany revenue stood at Rs 288 crore, by 8%. Constant currency revenue at Euro 31 million was up by 6%. Growth momentum continues with incremental tender wins since last five quarters. The company's US revenue stood at Rs 268 crore in Q2 FY25, up by 8%. Constant currency revenue was at $32 million, up by 7% YoY. Sequential quarter sales were at a similar level. Torrent Pharmaceuticals is the flagship company of the Torrent Group. It is ranked 6th in the Indian Pharmaceuticals Market and is amongst the top five in the therapeutics segments of cardiovascular (CV), gastro intestinal (GI), central nervous system (CNS), vitamins minerals nutritional (VMN) and cosmo-dermatology. Shares of Torrent Pharmaceuticals rallied 3.63% to end at Rs 3,436.65 on the BSE.Powered by Capital Market - Live
Net profit of Torrent Pharmaceuticals rose 17.36% to Rs 453.00 crore in the quarter ended September 2024 as against Rs 386.00 crore during the previous quarter ended September 2023. Sales rose 7.72% to Rs 2831.00 crore in the quarter ended September 2024 as against Rs 2628.00 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales2831.002628.00 8 OPM %33.1731.39 - PBDT859.00760.00 13 PBT661.00559.00 18 NP453.00386.00 17 Powered by Capital Market - Live
Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 25 October 2024.Powered by Capital Market - Live
Torrent Pharmaceuticals announced that Pranav Mehta has been elevated as Executive Director from Vice President of the company with effect from 01 April 2024. Powered by Capital Market - Live
Pharma shares rally; Suven, Granules, Ajanta, Jubilant surge over 5%
Torrent Pharmaceuticals set to acquire KKR’s stake in JB Chemicals
Torrent Pharma Q1 Results Review- Segment Continues To Drive Growth: Centrum
Stocks in news: HUL, Vedanta, DRL, L&T, Axis Bank, Torrent Pharma and Titagarh Rail
Torrent Pharma tanks 4% post Q1FY25 results; analysts update target prices
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 7.06%, vs industry avg of 9.03%
Decreasing Market Share
Over the last 5 years, market share decreased from 3.52% to 2.88%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 30.58%, vs industry avg of 15.28%